138 related articles for article (PubMed ID: 11441144)
21. Effects of gender on hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and LDL receptor in hereditary analbuminemia.
Shin Y; Vaziri ND; Willekes N; Kim CH; Joles JA
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E993-8. PubMed ID: 16030068
[TBL] [Abstract][Full Text] [Related]
22. Increasing hepatic cholesterol 7alpha-hydroxylase reduces plasma cholesterol concentrations in normocholesterolemic and hypercholesterolemic rabbits.
Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Tint GS; Parker TS; Roberts J; Batta AK; Chen TS; Zhao Z; Kong X
Hepatology; 1996 Oct; 24(4):882-7. PubMed ID: 8855192
[TBL] [Abstract][Full Text] [Related]
23. Serum cholesterol, lecithin-cholesterol acyltransferase, and hepatic hydroxymethylglutaryl coenzyme A reductase activities of lean and obese Zucker rats.
Lin RC
Metabolism; 1985 Jan; 34(1):19-24. PubMed ID: 3965858
[TBL] [Abstract][Full Text] [Related]
24. Cholesterol metabolism in alloxan-induced diabetic rabbits.
O'Meara NM; Devery RA; Owens D; Collins PB; Johnson AH; Tomkin GH
Diabetes; 1990 May; 39(5):626-33. PubMed ID: 2332120
[TBL] [Abstract][Full Text] [Related]
25. Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents.
Karthikesan K; Pari L; Menon VP
Chem Biol Interact; 2010 Dec; 188(3):643-50. PubMed ID: 20696151
[TBL] [Abstract][Full Text] [Related]
26. Impaired serum lipids and lipoproteins in fetal macrosomia related to maternal obesity.
Merzouk H; Meghelli-Bouchenak M; Loukidi B; Prost J; Belleville J
Biol Neonate; 2000; 77(1):17-24. PubMed ID: 10658826
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
[TBL] [Abstract][Full Text] [Related]
28. Hepatic cholesterol metabolism in estrogen-treated men.
Angelin B; Olivecrona H; Reihnér E; Rudling M; Ståhlberg D; Eriksson M; Ewerth S; Henriksson P; Einarsson K
Gastroenterology; 1992 Nov; 103(5):1657-63. PubMed ID: 1426886
[TBL] [Abstract][Full Text] [Related]
29. Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats.
Thabet MA; Challa A; Chan JC; Pandak WM; Heuman DM; Vlahcevic ZR
Kidney Int; 1993 Oct; 44(4):789-94. PubMed ID: 8258956
[TBL] [Abstract][Full Text] [Related]
30. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring.
Yessoufou A; Soulaimann N; Merzouk SA; Moutairou K; Ahissou H; Prost J; Simonin AM; Merzouk H; Hichami A; Khan NA
Int J Obes (Lond); 2006 May; 30(5):739-50. PubMed ID: 16418759
[TBL] [Abstract][Full Text] [Related]
31. Hepatic cholesterol metabolism in human obesity.
Ståhlberg D; Rudling M; Angelin B; Björkhem I; Forsell P; Nilsell K; Einarsson K
Hepatology; 1997 Jun; 25(6):1447-50. PubMed ID: 9185766
[TBL] [Abstract][Full Text] [Related]
32. SC-435, an ileal apical sodium-codependent bile acid transporter inhibitor alters mRNA levels and enzyme activities of selected genes involved in hepatic cholesterol and lipoprotein metabolism in guinea pigs.
West KL; McGrane M; Odom D; Keller B; Fernandez ML
J Nutr Biochem; 2005 Dec; 16(12):722-8. PubMed ID: 16169202
[TBL] [Abstract][Full Text] [Related]
33. Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats.
LeBlanc MJ; Brunet S; Bouchard G; Lamireau T; Yousef IM; Gavino V; Lévy E; Tuchweber B
J Nutr Biochem; 2003 Jan; 14(1):40-8. PubMed ID: 12559476
[TBL] [Abstract][Full Text] [Related]
34. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
Vaziri ND; Liang K; Azad H
J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
[TBL] [Abstract][Full Text] [Related]
35. Increased sensitivity to dietary cholesterol in diabetic and hypothyroid rats associated with low levels of hepatic HMG-CoA reductase expression.
Ness GC; Gertz KR
Exp Biol Med (Maywood); 2004 May; 229(5):407-11. PubMed ID: 15096652
[TBL] [Abstract][Full Text] [Related]
36. Effects of single administration of pravastatin sodium on hepatic cholesterol metabolism in rats.
Fujioka T; Tsujita Y
Eur J Pharmacol; 1997 Apr; 323(2-3):223-8. PubMed ID: 9128842
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
[TBL] [Abstract][Full Text] [Related]
38. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
39. Regulation of hepatic cholesterol and lipoprotein metabolism in ethinyl estradiol-treated rats.
Erickson SK; Jaeckle S; Lear SR; Brady SM; Havel RJ
J Lipid Res; 1989 Nov; 30(11):1763-71. PubMed ID: 2614275
[TBL] [Abstract][Full Text] [Related]
40. Age-related changes in fatty acids in obese offspring of streptozotocin-induced diabetic rats.
Merzouk H; Madani S; Hichami A; Prost J; Belleville J; Khan NA
Obes Res; 2002 Jul; 10(7):703-14. PubMed ID: 12105294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
